MGB BIOPHARMA LIMITED
Company number SC362273 · Monitor this company
The annual accounts for this company are overdue.
The confirmation statement for this company is overdue.
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£9,140,758
Balance sheet as at 2023-08-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2009-07-07
- Registered office
- C/O QUANTUMA ADVISORY LIMITED, 86a George Street, Edinburgh, EH2 3BU
- Postcode
- EH2 3BU
- Capital
- 451 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2023-08-31
- Next due by
- 2025-05-31 Overdue
- Financial year end
- 31 August
Confirmation statement
- Last statement dated
- 2024-07-07
- Next due by
- 2025-07-21 Overdue
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current · 9 resigned
Sarah Catherine, Dr HARDY
Director
MR Kenneth Hall FYVIE
Director
MR Raymond John SPENCER
Director
Raymond John SPENCER
Secretary
DR Miroslav, Dr RAVIC
Director
Contact details
- Website
- mgb-biopharma.com
MGB Biopharma’s focus is to further develop their new class of anti-infective medicine with antibiotics based on Minor Groove Binder (MGBs) compounds.
Previous company names
| Name | Date changed |
|---|---|
| YORK PLACE (NO.536) LIMITED | 2009-09-28 |
Previous registered addresses 4
| Address | Changed on |
|---|---|
| C/O RAYMOND SPENCER, 151 WEST GEORGE STREET, GLASGOW, G2 2JJ, SCOTLAND | 2017-09-01 |
| 183 ST. VINCENT STREET, GLASGOW, G2 5QD | 2010-11-07 |
| GISTERED OFFICE CHANGED ON 01/10/2009 FROM, 30-31 QUEEN STREET, EDINBURGH, MIDLOTHIAN, EH2 1JX | 2009-10-01 |
| 30-31 QUEEN STREET, EDINBURGH, MIDLOTHIAN, EH2 1JX | 2009-10-01 |
The class of 2009
21%
of the 315,094 companies incorporated in 2009 are still active today; 77% have since been dissolved.
A fact about the year, not a forecast for this company.